Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 115 entries
Sorted by: Best Match Show Resources per page
Towards High Capacity Li-ion Batteries Based on Silicon-Graphene Composite Anodes and Sub-micron V-doped LiFePO.

Scientific reports

Loveridge MJ, Lain MJ, Johnson ID, Roberts A, Beattie SD, Dashwood R, Darr JA, Bhagat R.
PMID: 27898104
Sci Rep. 2016 Nov 29;6:37787. doi: 10.1038/srep37787.

Lithium iron phosphate, LiFePO

Cite
Loveridge MJ, Lain MJ, Johnson ID, et al. Towards High Capacity Li-ion Batteries Based on Silicon-Graphene Composite Anodes and Sub-micron V-doped LiFePO. Sci Rep. 2016;6:37787doi: 10.1038/srep37787.
Loveridge, M. J., Lain, M. J., Johnson, I. D., Roberts, A., Beattie, S. D., Dashwood, R., Darr, J. A., & Bhagat, R. (2016). Towards High Capacity Li-ion Batteries Based on Silicon-Graphene Composite Anodes and Sub-micron V-doped LiFePO. Scientific reports, 637787. https://doi.org/10.1038/srep37787
Loveridge, M J, et al. "Towards High Capacity Li-ion Batteries Based on Silicon-Graphene Composite Anodes and Sub-micron V-doped LiFePO." Scientific reports vol. 6 (2016): 37787. doi: https://doi.org/10.1038/srep37787
Loveridge MJ, Lain MJ, Johnson ID, Roberts A, Beattie SD, Dashwood R, Darr JA, Bhagat R. Towards High Capacity Li-ion Batteries Based on Silicon-Graphene Composite Anodes and Sub-micron V-doped LiFePO. Sci Rep. 2016 Nov 29;6:37787. doi: 10.1038/srep37787. PMID: 27898104; PMCID: PMC5127186.
Copy Download .nbib Format: NLM
Developmental-behavioral profiles in children with autism spectrum disorder and co-occurring gastrointestinal symptoms.

Autism research : official journal of the International Society for Autism Research

Restrepo B, Angkustsiri K, Taylor SL, Rogers SJ, Cabral J, Heath B, Hechtman A, Solomon M, Ashwood P, Amaral DG, Nordahl CW.
PMID: 32767543
Autism Res. 2020 Oct;13(10):1778-1789. doi: 10.1002/aur.2354. Epub 2020 Aug 06.

Gastrointestinal (GI) symptoms are frequently reported in children with autism spectrum disorder (ASD). We evaluated the frequency and severity of GI symptoms in preschool-aged children with ASD compared to participants with typical development (TD). Our goal was to ascertain...

Cite
Restrepo B, Angkustsiri K, Taylor SL, et al. Developmental-behavioral profiles in children with autism spectrum disorder and co-occurring gastrointestinal symptoms. Autism Res. 2020;13(10):1778-1789doi: 10.1002/aur.2354.
Restrepo, B., Angkustsiri, K., Taylor, S. L., Rogers, S. J., Cabral, J., Heath, B., Hechtman, A., Solomon, M., Ashwood, P., Amaral, D. G., & Nordahl, C. W. (2020). Developmental-behavioral profiles in children with autism spectrum disorder and co-occurring gastrointestinal symptoms. Autism research : official journal of the International Society for Autism Research, 13(10), 1778-1789. https://doi.org/10.1002/aur.2354
Restrepo, Bibiana, et al. "Developmental-behavioral profiles in children with autism spectrum disorder and co-occurring gastrointestinal symptoms." Autism research : official journal of the International Society for Autism Research vol. 13,10 (2020): 1778-1789. doi: https://doi.org/10.1002/aur.2354
Restrepo B, Angkustsiri K, Taylor SL, Rogers SJ, Cabral J, Heath B, Hechtman A, Solomon M, Ashwood P, Amaral DG, Nordahl CW. Developmental-behavioral profiles in children with autism spectrum disorder and co-occurring gastrointestinal symptoms. Autism Res. 2020 Oct;13(10):1778-1789. doi: 10.1002/aur.2354. Epub 2020 Aug 06. PMID: 32767543; PMCID: PMC7689713.
Copy Download .nbib Format: NLM
Rapid Communication: Plasma Interleukin-35 in Children with Autism.

Brain sciences

Rose D, Ashwood P.
PMID: 31252635
Brain Sci. 2019 Jun 27;9(7). doi: 10.3390/brainsci9070152.

In autism spectrum disorders (ASD) many individuals have co-morbid immune dysregulation that can lead to inflammation in the brain and periphery. The novel cytokine interleukin (IL)-35 has described anti-inflammatory properties; however, the plasma levels of IL-35 in children with...

Cite
Rose D, Ashwood P. Rapid Communication: Plasma Interleukin-35 in Children with Autism. Brain Sci. 2019;9(7)doi: 10.3390/brainsci9070152.
Rose, D., & Ashwood, P. (2019). Rapid Communication: Plasma Interleukin-35 in Children with Autism. Brain sciences, 9(7), . https://doi.org/10.3390/brainsci9070152
Rose, Destanie, and Ashwood, Paul. "Rapid Communication: Plasma Interleukin-35 in Children with Autism." Brain sciences vol. 9,7 (2019). doi: https://doi.org/10.3390/brainsci9070152
Rose D, Ashwood P. Rapid Communication: Plasma Interleukin-35 in Children with Autism. Brain Sci. 2019 Jun 27;9(7). doi: 10.3390/brainsci9070152. PMID: 31252635; PMCID: PMC6680732.
Copy Download .nbib Format: NLM
2-Thiouracil intersystem crossing photodynamics studied by wavelength-dependent photoelectron and transient absorption spectroscopies.

Physical chemistry chemical physics : PCCP

Sánchez-Rodríguez JA, Mohamadzade A, Mai S, Ashwood B, Pollum M, Marquetand P, González L, Crespo-Hernández CE, Ullrich S.
PMID: 28630971
Phys Chem Chem Phys. 2017 Aug 02;19(30):19756-19766. doi: 10.1039/c7cp02258a.

Single-atom substitution within a natural nucleobase-such as replacing oxygen by sulfur in uracil-can result in drastic changes in the relaxation dynamics after UV excitation. While the photodynamics of natural nucleobases like uracil are dominated by pathways along singlet excited...

Cite
Sánchez-Rodríguez JA, Mohamadzade A, Mai S, et al. 2-Thiouracil intersystem crossing photodynamics studied by wavelength-dependent photoelectron and transient absorption spectroscopies. Phys Chem Chem Phys. 2017;19(30):19756-19766doi: 10.1039/c7cp02258a.
Sánchez-Rodríguez, J. A., Mohamadzade, A., Mai, S., Ashwood, B., Pollum, M., Marquetand, P., González, L., Crespo-Hernández, C. E., & Ullrich, S. (2017). 2-Thiouracil intersystem crossing photodynamics studied by wavelength-dependent photoelectron and transient absorption spectroscopies. Physical chemistry chemical physics : PCCP, 19(30), 19756-19766. https://doi.org/10.1039/c7cp02258a
Sánchez-Rodríguez, José A, et al. "2-Thiouracil intersystem crossing photodynamics studied by wavelength-dependent photoelectron and transient absorption spectroscopies." Physical chemistry chemical physics : PCCP vol. 19,30 (2017): 19756-19766. doi: https://doi.org/10.1039/c7cp02258a
Sánchez-Rodríguez JA, Mohamadzade A, Mai S, Ashwood B, Pollum M, Marquetand P, González L, Crespo-Hernández CE, Ullrich S. 2-Thiouracil intersystem crossing photodynamics studied by wavelength-dependent photoelectron and transient absorption spectroscopies. Phys Chem Chem Phys. 2017 Aug 02;19(30):19756-19766. doi: 10.1039/c7cp02258a. PMID: 28630971.
Copy Download .nbib Format: NLM
Is Better Patient Safety Associated with Less Malpractice Activity?: Evidence from California.

Rand health quarterly

Greenberg MD, Haviland AM, Ashwood JS, Main R.
PMID: 28083157
Rand Health Q. 2011 Mar 01;1(1):1. eCollection 2011.

In principle, efforts to improve patient safety, if they are successful, should lead to reductions in claims of medical malpractice. In practice, however, this has not yet been systematically demonstrated to be so. The authors examined the relationship between...

Cite
Greenberg MD, Haviland AM, Ashwood JS, et al. Is Better Patient Safety Associated with Less Malpractice Activity?: Evidence from California. Rand Health Q. 2011;1(1):1
Greenberg, M. D., Haviland, A. M., Ashwood, J. S., & Main, R. (2011). Is Better Patient Safety Associated with Less Malpractice Activity?: Evidence from California. Rand health quarterly, 1(1), 1.
Greenberg, Michael D, et al. "Is Better Patient Safety Associated with Less Malpractice Activity?: Evidence from California." Rand health quarterly vol. 1,1 (2011): 1.
Greenberg MD, Haviland AM, Ashwood JS, Main R. Is Better Patient Safety Associated with Less Malpractice Activity?: Evidence from California. Rand Health Q. 2011 Mar 01;1(1):1. eCollection 2011. PMID: 28083157; PMCID: PMC4945208.
Copy Download .nbib Format: NLM
Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis.

Oncotarget

Lombardi B, Ashford P, Moya-Garcia AA, Rust A, Crawford M, Williams SV, Knowles MA, Katan M, Orengo C, Godovac-Zimmermann J.
PMID: 29262532
Oncotarget. 2017 Oct 25;8(61):102898-102911. doi: 10.18632/oncotarget.22048. eCollection 2017 Nov 28.

The FGFR3-TACC3 fusion is an oncogenic driver in diverse malignancies, including bladder cancer, characterized by upregulated tyrosine kinase activity. To gain insights into distinct properties of FGFR3-TACC3 down-stream signalling, we utilised telomerase-immortalised normal human urothelial cell lines expressing either...

Cite
Lombardi B, Ashford P, Moya-Garcia AA, et al. Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis. Oncotarget. 2017;8(61):102898-102911doi: 10.18632/oncotarget.22048.
Lombardi, B., Ashford, P., Moya-Garcia, A. A., Rust, A., Crawford, M., Williams, S. V., Knowles, M. A., Katan, M., Orengo, C., & Godovac-Zimmermann, J. (2017). Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis. Oncotarget, 8(61), 102898-102911. https://doi.org/10.18632/oncotarget.22048
Lombardi, Benedetta, et al. "Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis." Oncotarget vol. 8,61 (2017): 102898-102911. doi: https://doi.org/10.18632/oncotarget.22048
Lombardi B, Ashford P, Moya-Garcia AA, Rust A, Crawford M, Williams SV, Knowles MA, Katan M, Orengo C, Godovac-Zimmermann J. Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis. Oncotarget. 2017 Oct 25;8(61):102898-102911. doi: 10.18632/oncotarget.22048. eCollection 2017 Nov 28. PMID: 29262532; PMCID: PMC5732698.
Copy Download .nbib Format: NLM
Proximity to School and Physical Activity Among Middle School Girls: The Trial of Activity for Adolescent Girls Study.

Journal of physical activity & health

Cohen DA, Ashwood S, Scott M, Overton A, Evenson KR, Voorhees CC, Bedimo-Rung A, McKenzie TL.
PMID: 28834509
J Phys Act Health. 2006 Feb;3:S129-S138. doi: 10.1123/jpah.3.s1.s129.

BACKGROUND: Proximity to routine destinations is an important correlate of physical activity. We examined the association between distance from school and physical activity in adolescent girls.METHODS: We mapped the addresses of 1554 sixth-grade girls who participated in the Trial...

Cite
Cohen DA, Ashwood S, Scott M, et al. Proximity to School and Physical Activity Among Middle School Girls: The Trial of Activity for Adolescent Girls Study. J Phys Act Health. 2006;3:S129-S138doi: 10.1123/jpah.3.s1.s129.
Cohen, D. A., Ashwood, S., Scott, M., Overton, A., Evenson, K. R., Voorhees, C. C., Bedimo-Rung, A., & McKenzie, T. L. (2006). Proximity to School and Physical Activity Among Middle School Girls: The Trial of Activity for Adolescent Girls Study. Journal of physical activity & health, 3S129-S138. https://doi.org/10.1123/jpah.3.s1.s129
Cohen, Deborah A, et al. "Proximity to School and Physical Activity Among Middle School Girls: The Trial of Activity for Adolescent Girls Study." Journal of physical activity & health vol. 3 (2006): S129-S138. doi: https://doi.org/10.1123/jpah.3.s1.s129
Cohen DA, Ashwood S, Scott M, Overton A, Evenson KR, Voorhees CC, Bedimo-Rung A, McKenzie TL. Proximity to School and Physical Activity Among Middle School Girls: The Trial of Activity for Adolescent Girls Study. J Phys Act Health. 2006 Feb;3:S129-S138. doi: 10.1123/jpah.3.s1.s129. PMID: 28834509.
Copy Download .nbib Format: NLM
Evaluation Design Recommendations for the Certified Community Behavioral Health Clinic Demonstration Program.

Rand health quarterly

Breslau J, Ashwood JS, Kase CA, Pincus HA, Lovejoy SL.
PMID: 28845359
Rand Health Q. 2017 Jun 19;6(3):7. eCollection 2017 Jun.

This article provides information and recommendations regarding the evaluation design of the Certified Community Behavioral Health Clinic (CCBHC) demonstration. Mandated by Congress in Section 223 of the Protecting Access to Medicare Act of 2014, the CCBHC is a new...

Cite
Breslau J, Ashwood JS, Kase CA, et al. Evaluation Design Recommendations for the Certified Community Behavioral Health Clinic Demonstration Program. Rand Health Q. 2017;6(3):7
Breslau, J., Ashwood, J. S., Kase, C. A., Pincus, H. A., & Lovejoy, S. L. (2017). Evaluation Design Recommendations for the Certified Community Behavioral Health Clinic Demonstration Program. Rand health quarterly, 6(3), 7.
Breslau, Joshua, et al. "Evaluation Design Recommendations for the Certified Community Behavioral Health Clinic Demonstration Program." Rand health quarterly vol. 6,3 (2017): 7.
Breslau J, Ashwood JS, Kase CA, Pincus HA, Lovejoy SL. Evaluation Design Recommendations for the Certified Community Behavioral Health Clinic Demonstration Program. Rand Health Q. 2017 Jun 19;6(3):7. eCollection 2017 Jun. PMID: 28845359; PMCID: PMC5568152.
Copy Download .nbib Format: NLM
Inflammatory macrophage phenotype in BTBR T+tf/J mice.

Frontiers in neuroscience

Onore CE, Careaga M, Babineau BA, Schwartzer JJ, Berman RF, Ashwood P.
PMID: 24062633
Front Neurosci. 2013 Sep 17;7:158. doi: 10.3389/fnins.2013.00158. eCollection 2013.

Although autism is a behaviorally defined disorder, many studies report an association with increased pro-inflammatory cytokine production. Recent characterization of the BTBR T+tf/J (BTBR) inbred mouse strain has revealed several behavioral characteristics including social deficits, repetitive behavior, and atypical...

Cite
Onore CE, Careaga M, Babineau BA, et al. Inflammatory macrophage phenotype in BTBR T+tf/J mice. Front Neurosci. 2013;7:158doi: 10.3389/fnins.2013.00158.
Onore, C. E., Careaga, M., Babineau, B. A., Schwartzer, J. J., Berman, R. F., & Ashwood, P. (2013). Inflammatory macrophage phenotype in BTBR T+tf/J mice. Frontiers in neuroscience, 7158. https://doi.org/10.3389/fnins.2013.00158
Onore, Charity E, et al. "Inflammatory macrophage phenotype in BTBR T+tf/J mice." Frontiers in neuroscience vol. 7 (2013): 158. doi: https://doi.org/10.3389/fnins.2013.00158
Onore CE, Careaga M, Babineau BA, Schwartzer JJ, Berman RF, Ashwood P. Inflammatory macrophage phenotype in BTBR T+tf/J mice. Front Neurosci. 2013 Sep 17;7:158. doi: 10.3389/fnins.2013.00158. eCollection 2013. PMID: 24062633; PMCID: PMC3774991.
Copy Download .nbib Format: NLM
Chlorophylls as anticarcinogens (review).

International journal of oncology

Dashwood R.
PMID: 21533436
Int J Oncol. 1997 Apr;10(4):721-7. doi: 10.3892/ijo.10.4.721.

Chlorophylls, chlorins, and other porphyrins have been used clinically for many years, including photodynamic therapy of tumors. More recently, the cancer chemopreventive properties of chlorophylls have come to be recognized. Chlorophylls exhibit anti-mutagenic activity in short-term genotoxicity assays, and...

Cite
Dashwood R. Chlorophylls as anticarcinogens (review). Int J Oncol. 1997;10(4):721-7doi: 10.3892/ijo.10.4.721.
Dashwood, R. (1997). Chlorophylls as anticarcinogens (review). International journal of oncology, 10(4), 721-7. https://doi.org/10.3892/ijo.10.4.721
Dashwood, R. "Chlorophylls as anticarcinogens (review)." International journal of oncology vol. 10,4 (1997): 721-7. doi: https://doi.org/10.3892/ijo.10.4.721
Dashwood R. Chlorophylls as anticarcinogens (review). Int J Oncol. 1997 Apr;10(4):721-7. doi: 10.3892/ijo.10.4.721. PMID: 21533436.
Copy Download .nbib Format: NLM
The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Lyden PD, Ashwood T, Claesson L, Odergren T, Friday GH, Martin-Munley S.
PMID: 17895123
J Stroke Cerebrovasc Dis. 1998 Nov-Dec;7(6):435-41. doi: 10.1016/s1052-3057(98)80128-6.

Clomethiazole is a drug with sedative properties effective in laboratory studies of brain ischemia. A large European multicenter trial of clomethiazole in acute stroke patients showed no benefit overall, but subgroup analysis indicated that patients with large infarctions may...

Cite
Lyden PD, Ashwood T, Claesson L, et al. The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada. J Stroke Cerebrovasc Dis. 1998;7(6):435-41doi: 10.1016/s1052-3057(98)80128-6.
Lyden, P. D., Ashwood, T., Claesson, L., Odergren, T., Friday, G. H., & Martin-Munley, S. (1998). The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 7(6), 435-41. https://doi.org/10.1016/s1052-3057(98)80128-6
Lyden, P D, et al. "The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada." Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association vol. 7,6 (1998): 435-41. doi: https://doi.org/10.1016/s1052-3057(98)80128-6
Lyden PD, Ashwood T, Claesson L, Odergren T, Friday GH, Martin-Munley S. The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada. J Stroke Cerebrovasc Dis. 1998 Nov-Dec;7(6):435-41. doi: 10.1016/s1052-3057(98)80128-6. PMID: 17895123.
Copy Download .nbib Format: NLM
The clomethiazole acute stroke study (CLASS): efficacy results in 545 patients classified as total anterior circulation syndrome (TACS).

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Wahlgren NG, Bornhov S, Sharma A, Cederin B, Rosolacci T, Ashwood T, Claesson L.
PMID: 17895170
J Stroke Cerebrovasc Dis. 1999 Jul-Aug;8(4):231-9. doi: 10.1016/s1052-3057(99)80072-x.

The CLASS study showed no significant difference between treatment groups for the neuroprotectant clomethiazole compared with placebo. However, a beneficial effect of the drug was seen in patients with total anterior circulation syndrome (TACS). These are patients with clinical...

Cite
Wahlgren NG, Bornhov S, Sharma A, et al. The clomethiazole acute stroke study (CLASS): efficacy results in 545 patients classified as total anterior circulation syndrome (TACS). J Stroke Cerebrovasc Dis. 1999;8(4):231-9doi: 10.1016/s1052-3057(99)80072-x.
Wahlgren, N. G., Bornhov, S., Sharma, A., Cederin, B., Rosolacci, T., Ashwood, T., Claesson, L. (1999). The clomethiazole acute stroke study (CLASS): efficacy results in 545 patients classified as total anterior circulation syndrome (TACS). Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 8(4), 231-9. https://doi.org/10.1016/s1052-3057(99)80072-x
Wahlgren, N G, et al. "The clomethiazole acute stroke study (CLASS): efficacy results in 545 patients classified as total anterior circulation syndrome (TACS)." Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association vol. 8,4 (1999): 231-9. doi: https://doi.org/10.1016/s1052-3057(99)80072-x
Wahlgren NG, Bornhov S, Sharma A, Cederin B, Rosolacci T, Ashwood T, Claesson L. The clomethiazole acute stroke study (CLASS): efficacy results in 545 patients classified as total anterior circulation syndrome (TACS). J Stroke Cerebrovasc Dis. 1999 Jul-Aug;8(4):231-9. doi: 10.1016/s1052-3057(99)80072-x. PMID: 17895170.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 115 entries